ArticleBMC infectious diseases2026
Syphilis-related mortality in the United States, 2021-2025: trends, demographic disparities, and clinical implications.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSyphilis-related mortality in the United States remains incompletely characterized in the post-pandemic period. This study aimed to quantify trends, demographic disparities, and geographic distribution of syphilis-related mortality from 2021 to 2025 using multiple causes of death data, with attention to their clinical implications.
methodsA retrospective cross-sectional analysis was conducted using the CDC WONDER Multiple Cause-of-Death database. Decedents with ICD-10 codes A50-A53, listed as contributing causes, were included. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 population using the 2000 US Standard Population. Poisson regression was used to estimate the annual percent change (APC) for temporal trends and rate ratios (RRs) for demographic comparisons. Eight pre-specified sensitivity analyses were performed, including restriction to the underlying cause of death only and assessment of HIV and COVID-19 co-occurrence.
resultsA total of 1,148 syphilis-related deaths were identified, yielding an overall AAMR of 0.06 per 100,000 (95% CI: 0.06-0.07). No significant temporal trend was identified (APC: -1.24%, p = 0.550). Late-stage syphilis was recorded in 51.4% of deaths. The mortality rate among men was 2.5 times that of women (RR: 2.50; 95% CI: 2.20-2.83). The mortality among non-Hispanic Black individuals was 4.8 times that of non-Hispanic White individuals (RR: 4.81; 95% CI: 4.20-5.50). The South accounted for 50.3% of all deaths. HIV was co-listed in 27.5% of deaths, with a borderline increasing trend (APC: +8.25%; p = 0.047). More than half of the deaths occurred outside inpatient hospital settings.
conclusionsSyphilis-related mortality remained stable but was concentrated in identifiable high-risk groups and geographical areas. The predominance of late-stage disease, high HIV co-occurrence, and substantial proportion of deaths in community and long-term care settings may reflect gaps in early detection and treatment retention, although death certificate data cannot directly establish these mechanisms. These findings have implications for clinical practice, public health screening programs, and targeted interventions in high-burden populations. CLINICAL TRIAL NUMBER: Not Applicable.
Indexed as
Identifiers
42420885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.